JAMA
Original Investigation
February 3, 2015
John B. Holcomb, MD; Barbara C. Tilley, PhD; Sarah Baraniuk, PhD; Erin E. Fox, PhD; Charles E. Wade, PhD; Jeanette M. Podbielski, RN; Deborah J. del Junco, PhD; Karen J. Brasel, MD, MPH; Eileen M. Bulger, MD; Rachael A. Callcut, MD, MSPH; Mitchell Jay Cohen, MD; Bryan A. Cotton, MD, MPH; Timothy C. Fabian, MD; Kenji Inaba, MD; Jeffrey D. Kerby, MD, PhD; Peter Muskat, MD; Terence O’Keeffe, MBChB, MSPH; Sandro Rizoli, MD, PhD; Bryce R. H. Robinson, MD; Thomas M. Scalea, MD; Martin A. Schreiber, MS; Deborah M. Stein, MD; Jordan A. Weinberg, MD; Jeannie L. Callum, MD; John R. Hess, MD, MPH; Nena Matijevic, PhD; Christopher N. Miller, MD; Jean-Francois Pittet, MD; David B. Hoyt, MD; Gail D. Pearson, MD, ScD; Brian Leroux, PhD; Gerald van Belle, PhD; for the PROPPR Study Group
free access
JAMA. 2015; 313(5):471-482. 10.1001/jama.2015.12
This randomized trial reports that among patients with severe trauma and major bleeding, early administration of plasma, platelets, and red blood cells in a 1:1:1 ratio compared with a 1:1:2 ratio did not result in significant differences in mortality at 24 hours or at 30 days.
JAMA
Comment & Response
September 5, 2023
Pierre Bouzat, MD, PhD; Tobias Gauss, MD
JAMA. 2023; 330(9):876-876. 10.1001/jama.2023.11671
JAMA
Comment & Response
May 26, 2015
John B. Holcomb, MD; Erin E. Fox, PhD; Charles E. Wade, PhD; for the PROPPR Study Group
JAMA. 2015; 313(20):2078-2079. 10.1001/jama.2015.4427
JAMA
Comment & Response
May 26, 2015
Mohammad A. Helwani, MD, MSPH; Jason R. Gillihan, MD
JAMA. 2015; 313(20):2078-2078. 10.1001/jama.2015.4424
JAMA
Comment & Response
May 26, 2015
Michael T. McCurdy, MD; Alyson Liew-Spilger, BS; Mark Walsh, MD
JAMA. 2015; 313(20):2077-2078. 10.1001/jama.2015.4421
JAMA
Comment & Response
May 26, 2015
Hunter B. Moore, MD; Ernest E. Moore, MD; Eduardo Gonzalez, MD
JAMA. 2015; 313(20):2077-2077. 10.1001/jama.2015.4418